Syros Pharmaceuticals Newsroom

Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022

BenzingaNov 18 07:34 ET

Syros Pharmaceuticals Faces Financial Struggles Amid Key Challenges

TipRanksNov 18 07:27 ET

Express News | Syros Pharmaceuticals Inc - Appointment of Gerald Quirk, Esq., as President & CEO

ReutersNov 18 07:11 ET

Express News | Syros - Notified Conley Chee,CEO ,Jason Haas,CFO, David Roth, Chief Medical Officer That Employment of Such Officers Will Terminate Without Cause

ReutersNov 18 07:10 ET

Express News | Syros Pharmaceuticals Inc - Committed to Implementing a Reduction in Workforce by Approximately 94%

ReutersNov 18 07:05 ET

Express News | Syros Pharmaceuticals Inc - on Nov 15, Paid $33.5 Mln to Oxford in Partial Satisfaction of Its Obligations Under Loan Agreement

ReutersNov 18 07:05 ET

Express News | Syros Pharmaceuticals Inc - on Nov 14, 2024, Company Received Written Notice From Oxford of Trial Results Default

ReutersNov 18 07:04 ET

Express News | Syros Pharmaceuticals: In Connection With Termination of Agreement, Co to Pay Qiagen Certain Wind-Down & Other Costs & Other Final Payments

ReutersNov 18 07:04 ET

Express News | Syros Pharmaceuticals Inc - Termination Will Be Effective 90 Days Following Such Notice

ReutersNov 18 07:04 ET

Express News | Syros Pharmaceuticals - on Nov 13, Gave Notice to Qiagen Manchester of Its Election to Terminate Master Collaboration Agreement Dated March 7, 2022

ReutersNov 18 07:04 ET

Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal

Zacks Nov 14 09:35 ET

Insider Traders Lose US$250k As Syros Pharmaceuticals Drops

Simply Wall StNov 14 07:27 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 13 16:05 ET

Syros Cut to Neutral by H.C. Wainwright on Failed Drug Study

Seeking AlphaNov 13 11:51 ET

US Stocks Mixed; Inflation Rate Increases In October

BenzingaNov 13 10:02 ET

TD Cowen Maintains Syros Pharmaceuticals(SYRS.US) With Hold Rating

Moomoo NewsNov 13 08:31 ET · Ratings

Syros Pharmaceuticals Shares Plummet Premarket After Study Failure

WSJNov 13 08:14 ET

Express News | Syros Pharmaceuticals Shares Are Trading Lower After Multiple Firms Downgraded the Stock

BenzingaNov 13 08:12 ET

Express News | HC Wainwright & Co. Downgrades Syros Pharmaceuticals to Neutral, Lowers Price Target to $1

BenzingaNov 13 06:54 ET

Syros Pharmaceuticals Cut to Market Perform From Market Outperform by JMP Securities

Dow JonesNov 13 06:04 ET · Ratings